Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use INSULIN GLARGINE, U-300 safely and effectively. See full prescribing information for INSULIN GLARGINE, U-300. INSULIN GLARGINE, U-300, injection, for subcutaneous use Initial U.S. Approval: 2015 This product is TOUJEO® (insulin glargine).
Medication labelWhy this: Advisory · dailymed-prescription
Insulin Glargine, U-300 is indicated to improve glycemic control in adults and pediatric patients 6 years of age and older with diabetes mellitus. Limitations of Use: Insulin Glargine, U-300 is not recommended for the treatment of diabetic ketoacidosis.
- generic_name
- insulin glargine
- product_names
- insulin glargine
- ndc
- 0955-2900, 0955-3900, 0955-3900-01, 0955-3900-03, 0955-2900-01, 0955-2900-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en